Citadel Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Citadel Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,400	Closed	-$1.06K	–	15813
2023 Q1	$1.06K	Hold	2,400	–	–	﹤0.01%	14371
2022 Q4	$527	Buy	+2,400	New	+$718	﹤0.01%	14634
2022 Q2	–	Sell	-18,300	Closed	-$15K	–	14927
2022 Q1	$15K	Sell	18,300 -1,700	-9%	-$1.59K	﹤0.01%	13323
2021 Q4	$23K	Sell	20,000 -59,300	-75%	-$121K	﹤0.01%	13561
2021 Q3	$198K	Buy	79,300 +35,100	+79%	+$97.4K	﹤0.01%	12004
2021 Q2	$131K	Buy	44,200 +1,300	+3%	+$4.53K	﹤0.01%	12659
2021 Q1	$151K	Sell	42,900 -26,200	-38%	-$146K	﹤0.01%	12033
2020 Q4	$328K	Sell	69,100 -68,600	-50%	-$354K	﹤0.01%	8920
2020 Q3	$669K	Buy	137,700 +43,300	+46%	+$205K	﹤0.01%	6774
2020 Q2	$307K	Buy	+94,400	New	+$896K	﹤0.01%	7874

Other funds holding CEMI

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's CEMI Position: Q2 2023 in Review

Citadel Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 1,409 shares — an estimated $623 sold.

Citadel Advisors first reported a position in CEMI in Q1 2014 and held it in 15 quarters. The position peaked at $439K in Q3 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

Citadel Advisors reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 1,409 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $623.
Citadel Advisors first reported a position in Chembio diagnostics, Inc. in Q1 2014 and held it in 15 quarters.
Citadel Advisors's Chembio diagnostics, Inc. position peaked at $439K in Q3 2020.
1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.